Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 2
2013 3
2014 1
2015 8
2016 2
2017 6
2018 9
2019 3
2020 7
2021 10
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
A Fullerene-Platinum Complex for Direct Functional Patterning of Single Metal Atom-Embedded Carbon Nanostructures.
Yang D, Chen X, He D, Frommhold A, Shi X, Boden SA, Lebedeva MA, Ershova OV, Palmer RE, Li Z, Shi H, Gao J, Pan M, Khlobystov AN, Chamberlain TW, Robinson APG. Yang D, et al. Among authors: ershova ov. J Phys Chem Lett. 2022 Feb 17;13(6):1578-1586. doi: 10.1021/acs.jpclett.1c03877. Epub 2022 Feb 9. J Phys Chem Lett. 2022. PMID: 35138106 Free article.
Early Response of Antimicrobial Resistance and Virulence Genes Expression in Classical, Hypervirulent, and Hybrid hvKp-MDR Klebsiella pneumoniae on Antimicrobial Stress.
Fursova AD, Fursov MV, Astashkin EI, Novikova TS, Fedyukina GN, Kislichkina AA, Alexandrova IA, Ershova ON, Dyatlov IA, Fursova NK. Fursova AD, et al. Among authors: ershova on. Antibiotics (Basel). 2021 Dec 22;11(1):7. doi: 10.3390/antibiotics11010007. Antibiotics (Basel). 2021. PMID: 35052884 Free PMC article.
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ; SURPASS-4 Investigators. Del Prato S, et al. Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18. Lancet. 2021. PMID: 34672967 Clinical Trial.
57 results